Rankings
▼
Calendar
GUTS
Fractyl Health, Inc. Common Stock
$34M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$37M
Net Income
-$39M
EPS (Diluted)
$-1.12
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$34M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$103M
Total Liabilities
$312M
Stockholders' Equity
-$209M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$770,000
+100.0%
Operating Income
-$37M
-$29M
-27.5%
Net Income
-$39M
-$30M
-27.1%
← Q4 2020
All Quarters
Q1 2021 →
GUTS FY 2021 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena